PharmaBoardroom

Morocco Local Production Snapshot

A new IQVIA study sponsored by LEMM, the Moroccan association of multinationals looked at 3,437 references sold on the private market, which…

Roche’s Coronavirus Test Gets FDA Emergency Use…

Over the past few years, innovative Swiss giant Roche has combined its position as the world’s number 1 biotech company and its strength in in vitro…

China’s Clover Biopharmaceuticals Partners with GSK on…

Chinese biotech Clover Biopharmaceuticals may have flown under the radar thus far but it has stepped into the global limelight recently by partnering…

Greg Reh – Global Life Sciences & Health Care Leader,…

Greg Reh leads Deloitte’s global life sciences sector which includes clients in biopharma, medtech, generics and distribution businesses, as well as…

Iulia Arif-Percă – Executive Director, Local American…

Iulia Arif-Percă executive director of the Local American Working Group (LAWG), shares her insights on the launched initiatives to finding new…

Tom O’Leary – CIO, ICON

In an exclusive and wide-ranging interview, Tom O'Leary, chief information officer (CIO) of leading contract research organisation (CRO), ICON,…

COVID-19: A Material Disruptor

Regular PharmaBoardroom contributor David Crean looks at how the ongoing global coronavirus outbreak has impacted the global economy, how the…

The New Belgian Act on Medicinal Product Shortages

On 3 February 2020 the Act of 20 December 2019 amending various legal provisions concerning shortages of medicinal products was published in…

Chiesi Moves into Rare Diseases & the US Market

Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based subsidiary focusing on rare and ultra-rare…

US FDA New Drug Approvals 2019 Snapshot

Annual numbers of new molecular entities (NMEs) and biologics license applications (BLAs) approved by the FDA's Center for Drug Evaluation and…

Barbara Lopez Kunz – CEO, Drug Information Association…

Barbara Lopez Kunz, CEO of the Drug Information Association (DIA) in the USA, outlines the association’s four key areas of focus – regulatory…

Indian Pharma Supply Chain Hit by Coronavirus Outbreak

The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions for Indian pharma manufacturers and…

Tagged with US